Jochen Walz, Alexander Haese, Vincenzo Scattoni, Thomas Steuber, Felix K. H. Chun, Alberto Briganti, Francesco Montorsi, Markus Graefen, Hartwig Huland and Pierre I. Karakiewicz Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower Cancer 113
Version of Record online: 13 OCT 2008 | DOI: 10.1002/cncr.23885
The risk of prostate cancer is evident in patients with prostate-specific antigen (PSA) ≤2.5 ng/mL. Percent free PSA can accurately predict the prevalence of prostate cancer at prostate biopsy in these individuals.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field